Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review.

Contraception - 1 Jul 2026

Tepper Naomi K, Nguyen Antoinette T, Curtis Kathryn M, Baumhart Caitlin, Schieve Laura, Whiteman Maura K

Abstract excerpt

OBJECTIVES: Thrombophilia is associated with an elevated risk of thrombosis, which may be further elevated with the use of hormonal contraception. Our objective was to update a previously published systematic review on thrombosis risk with the use of hormonal contraception among women with thrombophilia. STUDY DESIGN: We conducted a systematic review of five databases from database inception through December 8,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraceptives, Oral, Hormonal
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prothrombin

Share to Risk Factors

Share to Thromboembolism

Share to Thrombophilia

Share to Thrombosis

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 40350005
DOI: 10.1016/j.contraception.2025.110943
PMCID: PMC12369957

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review.PMID 40350005Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

Hormonal contraception, thrombosis and age.Semantic proximity Read ↗

Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review.Semantic proximity Read ↗

Venous thrombosis and women's health : identification of risk factors and long terms effectsSemantic proximity Read ↗

Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.Semantic proximity Read ↗

Anticoagulation and in vitro fertilization and ovarian stimulationSemantic proximity Read ↗

Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis.Semantic proximity Read ↗

HORMONE EXPOSURE AND VENOUS THROMBOEMBOLISM IN COMMERCIALLY-INSURED WOMEN 50 TO 64 YEARS OF AGESemantic proximity Read ↗

Integrating Pharmacokinetic, Pharmacogenomic, and Clinical Risk Data to Individualise Hormonal Contraception and Minimise Thrombotic Risk: A Translational Framework.Semantic proximity Read ↗

The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.